Literature DB >> 16469809

Brain uptake of intranasally applied radioiodinated leptin in Wistar rats.

Stephanie Fliedner1, Carla Schulz, Hendrik Lehnert.   

Abstract

Leptin is mainly synthesized and secreted by fat cells in proportion to adipose tissue mass. Under physiological conditions, this hormone reduces food intake and increases thermogenesis through interactions with neurons in the central nervous system. However, transport of leptin into the central nervous system via the blood-brain barrier is saturable, and in obesity the feedback signal to the brain is markedly insufficient. In recent experiments we have shown, that intranasal (i.n.) delivery of leptin reduces food intake in rats. The aim of the present study was to explore the distribution of i.n. delivered leptin within brain, blood, and peripheral tissues. Application of [(125)I]leptin (0.03, 0.1, and 0.2 mg/kg) into male Wistar rats' nares (n = 8 per group) leads to supraphysiological brain leptin concentrations 30 min after application, with contents in the hypothalamus (7.3 +/- 2.6, 5.9 +/- 1.6, and 13.8 +/- 5.7 ng/g; P = 0.023; F = 6.157) being significantly higher than the brain average (1.2 +/- 0.2, 3.9 +/- 1.0, and 6.0 +/- 1.9 ng/g). In contrast, contents in the occipital/entorhinal cortex were lower than the brain average, indicating a minor participation of the transport via cerebrospinal fluid, which would have favored cerebrospinal fluid-exposed surfaces. In experiments employing the application of unlabeled leptin administered iv, we were able to show that excess blood leptin does not diminish brain uptake of i.n. leptin (as indicated by [(125)I]leptin), supporting a direct transport from nose to brain by circumvention of the blood-brain barrier. This study thus clearly demonstrates a rapid and highly effective transport of leptin from nose to brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469809     DOI: 10.1210/en.2005-1016

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  25 in total

1.  Role of leptin as antioxidant in obstructive sleep apnea: an in vitro study using electron paramagnetic resonance method.

Authors:  Madalina Macrea; Thomas Martin; Leon Zagrean; Zhenquan Jia; Hara Misra
Journal:  Sleep Breath       Date:  2012-02-04       Impact factor: 2.816

2.  Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity.

Authors:  Dongfen Yuan; Xiang Yi; Yuling Zhao; Chi-Duen Poon; Kristin M Bullock; Kim M Hansen; Therese S Salameh; Susan A Farr; William A Banks; Alexander V Kabanov
Journal:  J Control Release       Date:  2017-03-24       Impact factor: 9.776

3.  Nasal administration of leptin dose-dependently increases dopamine and serotonin outflow in the rat nucleus accumbens.

Authors:  Sonya Neto; Ramya Varatharajan; Kevin Joseph; Andreas Moser
Journal:  J Neural Transm (Vienna)       Date:  2016-07-13       Impact factor: 3.575

Review 4.  A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option.

Authors:  Asa Peterson; Amy Bansal; Florence Hofman; Thomas C Chen; Gabriel Zada
Journal:  J Neurooncol       Date:  2014-01-08       Impact factor: 4.130

Review 5.  Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans.

Authors:  Mitchel J R Ruigrok; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2015-02-19       Impact factor: 4.009

6.  Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents.

Authors:  Lin Xu; Nicholas Rensing; Xiao-Feng Yang; Hai Xia Zhang; Liu Lin Thio; Steven M Rothman; Aryan E Weisenfeld; Michael Wong; Kelvin A Yamada
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

7.  Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain.

Authors:  Leonardo H Tonelli; Andrew Holmes; Teodor T Postolache
Journal:  Neuropsychopharmacology       Date:  2007-06-27       Impact factor: 7.853

8.  Nanotechnology for CNS delivery of bio-therapeutic agents.

Authors:  Lipa Shah; Sunita Yadav; Mansoor Amiji
Journal:  Drug Deliv Transl Res       Date:  2013-08-01       Impact factor: 4.617

Review 9.  Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials.

Authors:  Armando P Signore; Feng Zhang; Zhongfang Weng; YanQin Gao; Jun Chen
Journal:  J Neurochem       Date:  2008-05-03       Impact factor: 5.372

Review 10.  mTOR and regulation of energy homeostasis in humans.

Authors:  Marwan Mannaa; Stephanie Krämer; Michael Boschmann; Maik Gollasch
Journal:  J Mol Med (Berl)       Date:  2013-06-12       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.